ArticleBJGP open2018
Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study.
Article in BJGP open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Primary care physicians' knowledge and confidence in providing cancer survivorship care: a systematic review.Journal of cancer survivorship : research and practice · 2024Pooled it
- Preferences of healthcare providers regarding future follow-up care for breast, prostate, and colorectal cancer: A discrete choice experiment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Interventions to Support Transitions in Care Among Patients With Cancer: A Scoping Review.Cancer medicine · 2025Article
- Acceptability of a shared cancer follow-up model of care between general practitioners and radiation oncologists: A qualitative evaluation.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Prostate cancer follow-up costs in Germany from 2000 to 2015.Journal of cancer survivorship : research and practice · 2022Article
- Exploring the experiences of patients, general practitioners and oncologists of prostate cancer follow-up: A qualitative interview study.European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe number of patients with prostate cancer is increasing, which puts additional pressure on health care. GP-led follow up may help reduce costs, travel time for patients, and workload for urologists and improve continuity of care.
aimTo test the feasibility and acceptability of a new clinical pathway for GP-led prostate cancer follow-up. DESIGN &
settingA feasibility pilot study was performed in cooperation with six GP practices in the Dutch region of Amersfoort.
methodThe study included 20 patients with prostate cancer in a stable phase, who were aged ≥65 years and with comorbidity. Follow-up for prostate cancer was transferred to the GP for one year. Participating GPs and urologists jointly developed a protocol. Patient satisfaction was measured at 0 and 12 months with the 'personalised care' subscale of the Consumer Quality (CQ) index 'general practice care'. Next, patients, GPs, and urologists were interviewed about their experiences. The clinical pathway was considered successful if no patients were referred back to the urologist, except for an increase in prostate-specific antigen (PSA), and if the majority of patients and participating urologists and GPs were satisfied.
resultsOf the 20 patients included in the study, three were referred back to the urologist because of increasing PSA levels and one died (unrelated to prostate cancer). Most patients (73%) were satisfied with the transfer of care, indicated by a score of ≥3 on the 'personalised care' subscale. GPs and urologists had confidence in the ability of GPs to provide follow-up care and preferred to continue this.
conclusionThe new clinical pathway was successful, warranting a larger study to provide evidence for the (cost-)effectiveness of GP-led prostate cancer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.